Jun 2026 (Q2 FY26) — Aug 4, 2026
Precigen Q2 FY26 — Strong PAP-SIMIUS Launch Drives Profitability
Read the full callPrecigen (PGEN) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Precigen earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 55.0 | +6322.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 41.2 | +3751.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 20.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$7.2 −2.17% · −$0.16
Performance +125.0% 1Y
1Y: $3.2 on 14 Oct 2025 → $7.2. High $8.56 (30 Sept 2026), low $3.1 (25 Mar 2026).
- Previous close
- $7.36
- 52-week range
- $3.1 – $8.56
- One year
- +103.97%
Overview
- Symbol
- PGEN
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Precigen earnings calls (PGEN)
Financials
What the filings say
Net profit, year on year: +175% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | — | — | 1 | 1 | — | — | 23 | 55 |
| Operating profit | — | — | -23 | -32 | — | — | -6 | 23 |
| Operating margin | — | — | −1685.0% | −3710.8% | — | — | −25.8% | 41.2% |
| Other income | — | — | -32 | 5 | — | — | -2 | -3 |
| Interest | — | — | 0 | 0 | — | — | 3 | 3 |
| Profit before tax | -24 | -20 | -54 | -27 | — | — | -8 | 20 |
| Tax rate | −0.1% | 0.4% | 0.0% | −0.0% | — | — | 0.0% | 0.0% |
| Net profit | -24 | -20 | -54 | -27 | -146 | -24 | -8 | 20 |
| EPS ($ per share) | -0.09 | — | -0.18 | -0.09 | -1.06 | — | -0.02 | 0.06 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | -1,331 | -1,653 | -1,823 | -1,916 | -1,869 | -1,964 | -2,091 | -2,341 |
| Total liabilities | 337 | 384 | 247 | 253 | 90 | 33 | 79 | 135 |
| Fixed assets | 87 | 44 | 35 | 9 | 7 | 7 | 14 | 14 |
| Investments | 120 | 9 | 48 | 72 | 51 | 55 | 68 | 68 |
| Total assets | 716 | 456 | 315 | 360 | 216 | 151 | 145 | 156 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -124 | -136 | -77 | -56 | -65 | -67 | -68 | -88 |
| Cash from investing | -151 | 87 | 28 | -75 | 226 | -3 | -21 | -2 |
| Cash from financing | 310 | 8 | 33 | 121 | -155 | 30 | 111 | 90 |
| Net cash flow | 35 | -42 | -16 | -9 | 5 | -41 | 22 | 1 |
| Capital expenditure | -42 | -38 | -8 | -7 | -5 | -2 | -9 | -2 |
| Free cash flow | -166 | -174 | -85 | -63 | -70 | -68 | -77 | -90 |
Insider filings
89 filings between Nov 19, 2025 and Sep 23, 2026.
Open market
decisions to buy or sellPurchases
$24.7K
1 purchase by 1 insider
Sales
$44.79M
42 sales by 7 insiders
24% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 8
- Award — granted as compensation
- 33
- Option exercise — converted options into shares
- 5
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| KIRK RANDAL J | — | $35.98M | Mar 30, 2026 |
| Sabzevari Helen | — | $2.56M | Jun 29, 2026 |
| KINDLER JEFFREY B | — | $2.23M | Aug 26, 2026 |
| Thomasian Harry Jr. | — | $1.90M | Jul 31, 2026 |
| Shah Rutul R | — | $1.26M | Aug 25, 2026 |
| Tennant Phil | — | $725.7K | Aug 25, 2026 |
| Lehr Donald P. | — | $127.0K | May 28, 2026 |
| AGEE NANCY H | $24.7K | — | Aug 21, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 10,744 | $50.7K |
| Sep 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 42,918 | $100.0K |
| Sep 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 2 | $2 |
| Sep 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 1 | $1 |
| Aug 26, 2026 | KINDLER JEFFREY B Director | Sale | 185,000 | $1.38M |
| Aug 25, 2026 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 plan | 15,342 | $35.7K |
| Aug 25, 2026 | Tennant Phil Chief Commercial Officer | Option exercise 10b5-1 plan | 79,166 | $127.5K |
| Aug 25, 2026 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 plan | 15,342 | $115.1K |
| Aug 25, 2026 | Tennant Phil Chief Commercial Officer | Sale 10b5-1 plan | 79,166 | $593.7K |
| Aug 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Tax withheld | 3,577 | $25.8K |
| Aug 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 7,291 | — |
| Aug 23, 2026 | Sabzevari Helen President and CEO | Tax withheld | 10,184 | $73.3K |
| Aug 23, 2026 | Tennant Phil Chief Commercial Officer | Option exercise 10b5-1 plan | 5,208 | — |
| Aug 23, 2026 | Lehr Donald P. Chief Legal Officer | Option exercise | 5,208 | — |
| Aug 23, 2026 | Shah Rutul R Chief Operating Officer | Tax withheld 10b5-1 plan | 3,647 | $26.3K |
| Aug 23, 2026 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 plan | 7,500 | — |
| Aug 23, 2026 | Tennant Phil Chief Commercial Officer | Tax withheld 10b5-1 plan | 2,585 | $18.6K |
| Aug 23, 2026 | Lehr Donald P. Chief Legal Officer | Tax withheld | 2,488 | $17.9K |
| Aug 23, 2026 | Sabzevari Helen President and CEO | Option exercise | 20,833 | — |
| Aug 21, 2026 | AGEE NANCY H Director | Purchase | 3,411 | $24.7K |
| Aug 21, 2026 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 plan | 34,658 | $259.9K |
| Aug 21, 2026 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 plan | 34,658 | $80.8K |
| Aug 6, 2026 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 plan | 32,739 | $224.6K |
| Aug 3, 2026 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 plan | 33,772 | $219.5K |
| Aug 3, 2026 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 plan | 33,772 | $78.7K |
| Jul 31, 2026 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 plan | 100,000 | $606.0K |
| Jul 1, 2026 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 plan | 171,429 | $948.0K |
| Jun 29, 2026 | Sabzevari Helen President and CEO | Option exercise 10b5-1 plan | 346,836 | $808.1K |
| Jun 29, 2026 | Shah Rutul R Chief Operating Officer | Option exercise 10b5-1 plan | 42,924 | $100.0K |
| Jun 29, 2026 | Thomasian Harry Jr. Chief Financial Officer | Sale 10b5-1 plan | 28,571 | $165.1K |
| Jun 29, 2026 | Shah Rutul R Chief Operating Officer | Sale 10b5-1 plan | 42,924 | $251.1K |
| Jun 29, 2026 | Sabzevari Helen President and CEO | Sale 10b5-1 plan | 346,836 | $2.04M |
| May 28, 2026 | Sabzevari Helen President and CEO | Sale | 119,250 | $519.9K |
| May 28, 2026 | Shah Rutul R Chief Operating Officer | Sale | 42,703 | $186.2K |
| May 28, 2026 | Lehr Donald P. Chief Legal Officer | Sale | 29,131 | $127.0K |
| May 28, 2026 | Thomasian Harry Jr. Chief Financial Officer | Sale | 41,884 | $182.6K |
| May 28, 2026 | Tennant Phil Chief Commercial Officer | Sale | 30,272 | $132.0K |
| May 23, 2026 | Shah Rutul R Chief Operating Officer | Option exercise | 90,000 | — |
| May 23, 2026 | Sabzevari Helen President and CEO | Option exercise | 250,000 | — |
| May 23, 2026 | Tennant Phil Chief Commercial Officer | Option exercise | 62,500 | — |
| May 23, 2026 | Lehr Donald P. Chief Legal Officer | Option exercise | 62,500 | — |
| May 23, 2026 | Thomasian Harry Jr. Chief Financial Officer | Option exercise | 87,500 | — |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 2,334,420 | $7.70M |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 1,108,998 | $3.66M |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 23,789 | $78.5K |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 38,976 | $128.6K |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 47,101 | $155.4K |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 168,794 | $557.0K |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 426,199 | $1.41M |
| Mar 30, 2026 | KIRK RANDAL J Director | Sale | 50,797 | $167.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for PRECIGEN, INC.
Free account. Everything above stays public.
Write why you follow PRECIGEN, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading